Shop
eStoreRx™
Online Supplement Dispensary
Easy direct-to-patient ordering & fulfilment for Lifelong Wellness, eStoreRx™ is offered as part of the WholePractice membership or as a stand-alone program.
For over 40 years, Biotics Research Corporation has revolutionized the nutritional supplement industry by utilizing “The Best of Science and Nature”. Combining nature’s principles with scientific ingenuity, our products magnify the nutritional
This inclusive membership contains all of the the tools you need to grow your business, including WholeLifeRx™, Nimativ®, WholeLifeQ™, eStoreRx™ and Practice Success Programs.
Easy direct-to-patient ordering & fulfilment for Lifelong Wellness, eStoreRx™ is offered as part of the WholePractice membership or as a stand-alone program.
April 29 2024
A new study published in the Journal of the American College of Cardiology provides some mechanistic insight into the benefits of physical activity fo...
A study published recently in Cell Reports Medicine showed that a ketogenic diet is safe, feasible, and may be a beneficial intervention for patients with autosomal-dominant polycystic kidney disease (ADPKD), which is the most common genetic cause of kidney failure.
The study compared a ketogenic diet (KD), periodic water fasting (WF), and a control diet, over three months. The control diet called for ad libitum food intake, while the WF arm called for subjects to do a 3-day water fast on 3 consecutive days within the first 14 days of each month of the trial (with all other days allowing for ad libitum food intake). The KD called for a maximum of 30 grams of carbohydrate per day and a moderate to low protein intake (0.8 g/kg body weight), with encouragement to limit meat intake, but this was not required.
Subjects on the KD had blood beta-hydroxybutyrate (BHB) and breath acetone measurements to confirm adherence. Only 9 of 23 subjects (39%) met the pre-determined threshold of 0.8 mmol/L for BHB concentration at three study visits, but 18 of 23 (78%) had levels ≥ 0.6 mmol/L at two of three visits, and the same number showed higher BHB levels at all on-diet visits compared with their baseline, suggesting at least some level of adherence.
Compared to the control and WF, subjects following the KD exhibited greater decreases in body fat mass and total liver volume. Subjects on the KD also showed greater decreases in total kidney volume but this did not reach significance. Compared to the control and WE groups – and contrary to the typical progressive decline in kidney function in patients with ADPKD – subjects on the KD actually showed improved kidney function, as measured by creatinine-based eGFR and cystatin C-based eGFR.
While more research is needed, the authors of this study noted, “…considering the usually relentless progressive loss of kidney function in ADPKD and the fact that the only available treatment slows eGFR decline by 26%–30% only, the findings of our study would be of very high clinical relevance if a disease-modifying effect can be confirmed in the future.”
See this previous article for more on the effects of carbohydrate restriction on chronic kidney disease and general renal function.
Submit this form and you'll receive our latest news and updates.
How the ketogenic influences the microbiota is a favorite research topic today. Some data suggests that ketogenic diets ...
Learn more
*These statements have not been evaluated by the Food and Drug Administration. This product has not intended to diagnose, treat, cure, or prevent any disease.
© 2023 Biotics Research Corporation - All Rights Reserved
Submit your comment